SHANNON HALL: Open Payments
NPI 1417310921 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 9 payments from 7 companies in 2025. Trend: 2023 $793 · 2024 $1,376 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $48 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: CREON, TRELEGY ELLIPTA, XYOSTED, GEMTESA, VRAYLAR, TRINTELLIX, BREZTRI, EVENITY.
Industry payments across AL — which companies pay providers there.
